Guayulin B



Compound IDCDAMM02124
Common nameGuayulin B
IUPAC name(4,8,11,11-tetramethyl-2-bicyclo[8.1.0]undeca-4,8-dienyl) 4-methoxybenzoate
Molecular formulaC23H30O3

Experimental data

Retention time7.43
Adduct[M+H]+
Actual mz355.227
Theoretical mz355.226
Error1.48
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.9091

Identifiers and class information

Inchi keyPSEUVXLMKIAASF-DWUXDIELNA-N
SmilesO=C(OC1CC(=CCCC(=CC2C1C2(C)C)C)C)C3=CC=C(OC)C=C3
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)3
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)1
Molecular weight (mol_MW)354.488
Computed dipole moment(dipole)3.79
Total solvent accessible surface area (SASA)634.527
Hydrophobic component of SASA (FOSA)473.695
Hydrophilic component of SASA (FISA)27.618
Pie component of the SASA (PISA)133.213
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1192.12
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)2.75
Free energy of solvation of dipole (dip^2/V)0.0120483
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.856895
Predicted polarizability in cubic angstroms (QPpolrz)40.9
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.442
Predicted octanol/gas partition coefficient (QPlogPoct)14.632
Predicted water/gas partition coefficient (QPlogPw)4.387
Predicted octanol/water partition coefficient (QPlogPo/w)5.698
Predicted aqueous solubility (QPlogS)-6.313
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.232
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.483
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)5419.97
Predicted brain/blood partition coefficient (QPlogBB)0.132
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)3074.07
Predicted skin permeability, log Kp (QPlogKp)-1.271
PM3 calculated ionization potential (IP(ev))9.055
PM3 calculated electron affinity (EA(eV))0.389
Number of likely metabolic reactions (#metab)7
Prediction of binding to human serum albumin (QPlogKhsa)1.216
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)34.52
Number of nitrogen and oxygen atoms (#NandO)3
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P17612PRKACAcAMP-dependent protein kinase alpha-catalytic subunitT12808SwissTargetPrediction
P06401PGRProgesterone receptorT22939SwissTargetPrediction
P17706PTPN2T-cell protein-tyrosine phosphataseT49156SwissTargetPrediction
P06746POLBDNA polymerase beta (by homology)T06958SwissTargetPrediction
Q14534SQLESqualene monooxygenase (by homology)T93344SwissTargetPrediction
O00767SCDAcyl-CoA desaturaseT10897SwissTargetPrediction
Q99572P2RX7P2X purinoceptor 7T63414SwissTargetPrediction
P34998CRHR1Corticotropin releasing factor receptor 1 (by homology)T45262SwissTargetPrediction
Q9Y2T6GPR55G-protein coupled receptor 55T87670SwissTargetPrediction
O75884RBBP9Putative hydrolase RBBP9T12084SEA
P32249EBI2EBV-induced G-protein coupled receptor 2T59577SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T12808DI0279Muscular atrophy[ICD-11: 8B61]P17612PRKACA
T22939DI0062Breast cancer[ICD-11: 2C60-2C6Y]P06401PGR
T22939DI0100Contraceptive management[ICD-11: QA21]P06401PGR
T22939DI0255Menstrual cycle bleeding disorder[ICD-11: GA20]P06401PGR
T22939DI0344Preterm labour/delivery[ICD-11: JB00]P06401PGR
T22939DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06401PGR
T49156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P17706PTPN2
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T93344DI0118Dermatophytosis[ICD-11: 1F28]Q14534SQLE
T93344DI0385Skin fungal infection disorder[ICD-11: EA60]Q14534SQLE
T10897DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O00767SCD
T63414DI0224Joint pain[ICD-11: ME82]Q99572P2RX7
T45262DI0394Staphylococcal/streptococcal disease[ICD-11: 1B5Y]P34998CRHR1
T87670DI0040Attention deficit hyperactivity disorder[ICD-11: 6A05]Q9Y2T6GPR55

Copyright © 2025